Your browser doesn't support javascript.
loading
Pralatrexate mediates effective killing of gemcitabine-resistant pancreatic cancer: role of mTOR/4E-BP1 signal pathway.
Weng, Wanwen; Hong, Jiawei; Owusu-Ansah, Kwabena G; Chen, Bingjie; Zheng, Shusen; Jiang, Donghai.
Afiliação
  • Weng W; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Hong J; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou 310003, China.
  • Owusu-Ansah KG; Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Hangzhou 310003, China.
  • Chen B; Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Zhejiang Province, Hangzhou 310003, China.
  • Zheng S; Department of Nuclear Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Jiang D; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Heliyon ; 8(12): e12064, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36544829
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China